JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2006; 48:1304-1309, doi:10.1016/j.jacc.2006.05.068 (Published online 11 September 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elezi, S.
Right arrow Articles by Kastrati, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elezi, S.
Right arrow Articles by Kastrati, A.
Related Collections
Right arrowRelated Article

Vessel Size and Outcome After Coronary Drug-Eluting Stent Placement

Results From a Large Cohort of Patients Treated With Sirolimus- or Paclitaxel-Eluting Stents

Shpend Elezi, MD*, Alban Dibra, MD*, Julinda Mehilli, MD*, Jürgen Pache, MD*, Rainer Wessely, MD*, Albert Schömig, MD{dagger} and Adnan Kastrati, MD*,*,1

* Deutsches Herzzentrum, Technische Universität, Munich, Germany
{dagger} First Medizinische Klinik rechts der Isar, Technische Universität, Munich, Germany.


Figure 1
View larger version (35K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Late lumen loss in each vessel size tertile with sirolimus-eluting stents and paclitaxel-eluting stents.

 

Figure 2
View larger version (32K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Target lesion revascularization rate in each vessel size tertile with sirolimus-eluting stents and paclitaxel-eluting stents. Note that a significant difference between the 2 drug-eluting stents is only seen among patients in the lower tertile.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.